US 11141378
Lipid formulations for nucleic acid delivery
granted A61KA61K31/713A61K48/0025
Quick answer
US patent 11141378 (Lipid formulations for nucleic acid delivery) held by ARBUTUS BIOPHARMA CORPORATION expires Mon Oct 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ARBUTUS BIOPHARMA CORPORATION
- Grant date
- Tue Oct 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K31/713, A61K48/0025, A61K9/1271, A61K9/1272